Search results
Société BIC And 2 Other Prominent Dividend Stocks On Euronext Paris
Simply Wall St. via Yahoo Finance· 4 days agoAmidst a backdrop of cautious optimism in European markets, where recent ECB rate cuts have stirred...
Euronext Paris Highlights 3 Dividend Stocks With Yields Up To 6.2%
Simply Wall St. via Yahoo Finance· 5 days agoAmidst a backdrop of cautious optimism in global markets, France's economy shows resilience, with...
Small Biotech Crushed On Obesity Switch After Glaucoma Flop
Investor's Business Daily· 4 days agoSkye Bioscience (SKYE) had been testing a treatment for a form of glaucoma. Now, Skye says it's...
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge | The Motley Fool
The Motley Fool· 3 days agoThe human lifespan has increased dramatically since the start of the 17th century, from an average...
Questor: Investors are undervaluing this London company’s pubs and hotels
The Telegraph via Yahoo Finance· 4 days agoWe are hopefully not tempting providence by taking a fresh look at Fuller Smith & Turner ahead of...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 4 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...
Kymera reports promising Phase 1 results for KT-333 cancer drug By Investing.com
Investing.com· 12 hours agoKymera Therapeutics Inc. (NASDAQ: KYMR), a biopharmaceutical firm focused on advancing protein...
FDA Panel Backs Eli Lilly's Biogen-Rivaling Alzheimer's Drug
Investor's Business Daily· 4 days agoThe panel later voted unanimously that the benefits of donanemab outweigh the risks for the types of...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks· 5 days agoFree Report) announced that the FDA has approved the expanded use of its respiratory syncytial virus (RSV) vaccine, Arexvy for adults aged 50-59 who are at increased risk of RSV disease. Arexvy ...
Health Care Roundup: Market Talk
The Wall Street Journal· 3 days agoThe brokerage initiates coverage of the stock with an add rating and a target price of THB58.00. In addition to the younger generation and females, males...